Austin, United States
Clairity, Inc., founded in 2020 and headquartered in the United States, is a promising player in the intersection of AI, Health Care, and Machine Learning. Embracing the slogan, "Fulfilling the promise of precision medicine through the power of AI," the company is dedicated to revolutionizing breast cancer screening through its mammography-based deep learning platform.
Clairity aims to democratize access to life-saving screening technology by improving diagnostic accuracy, eliminating bias, and reducing healthcare costs. Their approach holds the potential to significantly impact patient outcomes and foster trust in diagnostic procedures.
On October 17, 2022, Clairity secured a $6.67M Venture Round investment, underscoring investor confidence in their disruptive technology and potential for growth. As precision medicine continues to gain momentum, Clairity is strategically positioned to leverage its AI-driven platform for substantial impact and scalability in the health care sector.
